Risk stratification after acute myocardial infarction;Estratificación pronóstica tras infarto agudo de miocardio

Revista Espanola de Cardiologia

Volumn 56, Issue 3, 2003, Pages 303-313

  Candell Riera, Jaume ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Acute myocardial infarction; Prognosis

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DOBUTAMINE; GLYCERYL TRINITRATE; NITRIC ACID DERIVATIVE;

ACUTE HEART INFARCTION; ANGIOCARDIOGRAPHY; CELL VIABILITY; CORONARY ARTERY; ECHOCARDIOGRAPHY; EXERCISE TEST; HEALTH CARE AVAILABILITY; HEALTH CARE FACILITY; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE OVERLOAD; HEART MUSCLE REVASCULARIZATION; HOSPITALIZATION; HUMAN; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; RISK ASSESSMENT; STRATIFICATION; TREATMENT OUTCOME;

EID: 0038070648     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13043956     Document Type: Review

References (134)

1. Berman DS, Germano G. Clinical applications of nuclear cardiology. En: Germano G, Berman DS, editors. Armonk: Futura Publishing Co, 1999; p. 1-71.
2. Moss AJ, Benhorin J. Prognosis and management after a first myocardial infarction. N Engl J Med 1990;322:743-53.
3. Johnston TS, Wenger NK. Risk stratification after myocardial infarction. Curr Opin Cardiol 1993;8:621-8.
4. Sami M, Kraemer H, DeBusk RF. The prognostic significance of serial exercise testing after myocardial infarction. Circulation 1979;60:1238-46.
5. Théroux P, Waters DD, Halphen C, Debaisieux JC, Mizgala HF. Prognostic value of exercise testing soon after myocardial infarction. N Engl J Med 1979;301:341-5.
6. Alijarde M, Soler-Soler J, Pérez-Jabaloyes J, Bruguera J, Anívarro I. Significance of treadmill stress testing in transmural myocardial infarction. Correlation with coronary angiography. Eur Heart J 1982;3:353-61.
7. Velasco J, Tormo V, Ferrer LM, Ridocci F, Blanch S. Early exercise test for evaluation of long-term prognosis after uncomplicated myocardial infarction. Eur Heart J 1981;2:401-7.
8. Sullivan ID, Davies DW, Sowton E. Submaximal exercise testing early after myocardial infarction. Difficulty of predicting coronary anatomy and left ventricular performance. Br Heart J 1985;53:180-5.
9. Campbell S, A'Hern R, Quigley P, Vincent R, Jewitt D, Chamberlain D. Identification of patients at low risk of dying after acute myocardial infarction, by simple clinical and submaximal exercise test criteria. Eur Heart J 1988;9:938-47.
10. Peart I, Odemuyiwa O, Albers C, Hall A, Kelly C, Hall RJC. Exercise testing soon after myocardial infarction: its relation to course and outcome at one year in patients aged less than 55 years. Br Heart J 1989;61:231-7.
11. Silverman KJ, Becker LC, Bulkley BH, BuroW RD, Mellits ED, Kallman CH, et al. Value of early thallium-201 scintigraphy for predicting mortality in patients with acute myocardial infarction. Circulation 1980;61:996-1003.
12. Gibson RS, Watson DD, Carabello DA, Holt ND, Beller GA. Clinical implications of increased lung uptake of thallium-201 during exercise scintigraphy 2 weeks after myocardial infarction. Am J Cardiol 1982;49:1586-93.
13. Casanova R, Patroncini A, Guidalotti PL, Capacci PF, Jacopi F, Fabbri M, et al. Dose and test for dipyridamole infusion and cardiac imaging early after uncomplicated acute myocardial infarction. Am J Cardiol 1992;70:1402-6.
14. Murray DP, Murray G, Rafiqi E, Littler WA. Routine exercise testing or thallium-201 scintigraphy for prediction of cardiac events post-myocardial infarction? Eur J Nucl Med 1987;13:274-7.
15. Brown KA, Rowen M, O'Meara J, Chambers CE. Comparative prognostic value of dipyridamole-thallium-201 myocardial perfusion imaging 1-4 days after myocardial infarction versus routine predischarge submaximal exercise testing. Am J Noninvas Cardiol 1992;6:211-4.
16. Horowitz RS, Morganroth J. Immediate detection of early high-risk patients with acute myocardial infarction using two-dimensional echocardiographic evaluation of left ventricular regional wall motion abnormalities. Am Heart J 1982;103:814-22.
17. Visser CA, Res J, Jaarsma W. Utility of stress echocardiography for postinfarct prognosis. Echocardiography 1992;9:211-8.
18. Ryan T, Armstrong WF, O'Donnell JA, Feigenbaum H. Risk stratification after acute myocardial infarction by means of exercise two-dimensional echocardiography. Am Heart J 1987;114:1305-16.
19. Bhatnagar SK, Al-Yusuf AR, Nawaz MK, Bahar RH, Dayem HMA. Left ventricular function of survivors of a first complicated acute myocardial infarction. A prehospital discharge cross-sectional echocardiographic study. Int J Cardiol 1988;19:67-80.
20. Carrie D, Fauvel M, Douste-Blazy MY, Mordant B, Bernadet P. Valeur pronostique à 12 mois d'une échocardiographie bidimensionelle réalisée en phase aigüe d'un infarctus du myocarde. Etude prospective de 140 patients. Arch Mal Coeur 1988;81:1327-32.
21. Domingo E, Álvarez A, García-del-Castillo H, Lupon J, Figueras J, Soler Soler J. Prognostic value of segmental contractility assessed by cross-sectional echocardiography in first acute myocardial infarction. Eur Heart J 1989;10:532-7.
22. Corbett JR, Nicod P, Lewis SE, Rude RE, Willerson JT. Prognostic value of submaximal exercise radionuclide ventriculography after myocardial infarction. Am J Cardiol 1983;52:82A-91A.
23. Nicod P, Corbett JR, Firth BG, Lewis SE, Rude RE, Huxley R, et al. Prognostic value of resting and submaximal exercise radionuclide ventriculography after acute myocardial infarction in high-risk patients with single and multivessel disease. Am J Cardiol 1983;52:30-6.
24. Morris KG, Palmeri ST, Califf RM, McKinnis RA, Higginbotham MB, Coleman RE, et al. Value of radionuclide angiography for predicting specific cardiac events after acute myocardial infarction. Am J Cardiol 1985;55:318-24.
25. Abraham RD, Harris PJ, Roubin GS, Shen WF, Sadick N, Morris J, et al. Usefulness of ejection fraction response to exercise one month after acute myocardial infarction in predicting coronary anatomy and prognosis. Am J Cardiol 1987;60:225-30.
26. McGhie I, Willerson JT, Corbett JR. Radionuclide assessment of ventricular function and risk stratification after myocardial infarction. Circulation 1991;84(Suppl I):167-76.
27. Dwyer EM, McMaster P, Greenberg H. The multicenter postinfarction research group. Nonfatal cardiac events and recurrent infarction in the year after acute myocardial infarction. J Am Coll Cardiol 1984;4:695-702.
28. Olson HG, Lyons KP, Troop P, Butman S, Piters KM. The high-risk acute myocardial infarction patient at 1-year follow-up: Identification at hospital discharge by ambulatory electrocardiography and radionuclide ventriculography. Am Heart J 1984;107:358-66.
29. McClements BM, Adgey J. Value of signal-averaged electrocardiography, radionuclide ventriculography, Holter monitoring and clinical variables for prediction of arrhythmic events in survivors of acute myocardial infarction in the thrombolytic era. J Am Coll Cardiol 1993;21:1419-27.
30. Fioretti P, Brower RW, Simoons ML, Katen HT, Beelen A, Baardman T, et al. Relative value of clinical variables, bicycle ergometry, rest radionuclide ventriculography and 24 hour ambulatory electrocardiographic monitoring at discharge to predict 1 year survival after myocardial infarction. J Am Coll Cardiol 1986;8:40-9.
31. Gomes JA, Winters SL, Stewart D, Horowitz S, Milner M, Barreca P. A new noninvasive index to predict sustained ventricular tachycardia and sudden death in the first year after myocardial infarction: Based on signal-averaged electrocardiogram, radionuclide ejection fraction and Holter monitoring. J Am Coll Cardiol 1987;10:349-57.
32. Taylor GJ, Humphries JO, Mellits ED, Pitt B, Schulze RA, Griffith LSC, et al. Predictors of clinical course, coronary anatomy and left ventricular function after recovery from acute myocardial infarction. Circulation 1980;62:960-70.
33. DeFeyter PJ, Van Eenige MJ, Dighton DH, Visser FC, de Jong J, Roos JP. Prognostic value of exercise testing, coronary angiography and left ventriculography 6-8 weeks after myocardial infarction. Circulation 1982;66:527-36.
34. Betriu A, Castañer A, Sanz G, Paré JC, Roig E, Coll S, et al. Angiographic findings 1 month after myocardial infarction: a prospective study of 259 survivors. Circulation 1982;65:1099-105.
35. Sanz G, Castañer A, Betriu A, Magriñà J, Roig E, Coll S, et al. Determinants of prognosis in survivors of myocardial infarction. A prospective clinical angiographic study. N Engl J Med 1982;306:1065-70.
36. De Belder MA, Pumphrey CW, Skehan JD, Rimington H, Wakeel BA, Evans SJW, et al. Relative power of clinical, exercise test, and angiographic variables in predicting clinical outcome after myocardial infarction: the Newham and Tower Hamlets study. Br Heart J 1988;60:377-89.
37. Marchioli R, Avanzini F, Barzi F, Chieffo C, Di Castelnuovo A, Franzosi MG, et al. Assessment of absolute risk of death after myocardial infarction by use of multiple-risk-factor assessment equations. GISSI-Prevenzione mortality risk chart. Eur Heart J 2001;22:2085-103.
38. Candell-Riera J, Permanyer-Miralda G, Castell J, Rius-Daví A, Domingo E, Álvarez-Auñón E, et al. Uncomplicated first myocardial infarction: Strategy for comprehensive prognostic studies. J Am Coll Cardiol 1991;18:1207-19.
39. Olona M, Candell-Riera J, Permanyer-Miralda G, Castell J, Barrabés J, Domingo E, et al. Strategies for prognostic assessment of uncomplicated first myocardial infarction: A 5-years follow up study. J Am Coll Cardiol 1995;25:815-22.
40. Arós F, Boraita A, Alegría E, Alonso AM, Bardají A, Lamiel R, et al. Guías de práctica clínica de la Sociedad Española de Cardiología en pruebas de esfuerzo. Rev Esp Cardiol 2000;53:1063-94.
41. Candell-Riera J, Castell-Conesa J, Jurado-López JA, López de Sá E, Nuño de la Rosa JA, Ortigosa-Aso FJ, et al. Guías de actuación clínica de la Sociedad Española de Cardiología. Cardiología nuclear: Bases técnicas y aplicaciones clínicas. Rev Esp Cardiol 1999;52:957-89.
42. Cabadés A, López-Bescós L, Arós F, Loma-Osorio A, Bosch X, Pabón, et al en representación de los investigadores del estudio PRIAMHO. Variabilidad en el pronóstico a corto y medio plazo del infarto de miocardio en España: el estudio PRIAHMO. Rev Esp Cardiol 1999;52:767-75.
43. De Velasco JA, Cosín J, López-Sendón JL, De Teresa E, De Oya M, Sellers G. Nuevos datos sobre la prevención secundaria del infarto de miocardio en España. Resultados del estudio PREVESE II. Rev Esp Cardiol 2002;55:801-9.
44. 99mTc-tetrofosmin gated -SPECT. J Nucl Cardiol 2001;8:122-8.
45. Haber HL, Beller GA, Watson DD, Gimple LW. Exercise thallium-201 scintigraphy after thrombolytic therapy with or without angioplasty for acute myocardial infarction. Am J Cardiol 1993;71:1257-61.
46. Kulick DL, Rahimtoola SH. Risk stratification in survivors of acute myocardial infarction: routine cardiac catheterization and angiography is a reasonable approach in most patients. Am Heart J 1991;121:641-56.
47. Rouleau JL, Moyé LA, Pfeffer MA, Arnold JMO, Bernstein V, Cuddy TE, et al, for the SAVE investigators. A comparison of management patterns after acute myocardial infarction in Canada and the United States. N Engl J Med 1993;328:779-84.
48. Every NR, Larson EB, Litwin PE, Maynard C, Fihn SD, Eisenberg MS, et al, for the Myocardial Infarction Triage and Intervention Project Investigators. The association between on-site cardiac catheterization facilities and the use of coronary angiography after acute myocardial infarction. N Engl J Med 1993; 329:546-51.
49. Marrugat J, Sanz G, Masiá R, Valle V, Molina L, Cardona M, et al, for the RESCATE investigators. Six-month outcome in patients with myocardial infarction initially admitted to tertiary and nontertiary hospitals. J Am Coll Cardiol 1997;30:1187-92.
50. Boden WE, O'Rourke RA, Crawford MH, Blaustein AS, Deedwania PC, Zoble RG, et al, for the Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. N Engl J Med 1998;338:1785-92.
51. Mark DB, Naylor CD, Phil D, Hlatky MA, Califf RM, Topol EJ, et al. Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States. N Engl J Med 1994;331:1130-5.
52. Woods KL, Ketley D, Agusti A, Hagn C, Karatzas NB, Leizorowicz A, et al. Use of coronary angiography and revascularization procedures following acute myocardial infarction. A European perspective. Eur Heart J 1998;19:1348-54.
53. Turner JD, Schwartz KM, Logic JR, Sheffield LT, Kansal S, Roitman DI, et al. Detection of residual jeopardized myocardium 3 weeks after myocardial infarction by exercise testing with thallium-201 myocardial scintigraphy. Circulation 1980;61:729-37.
54. Dakik HA, Mahmarian JJ, Kimball KT, Koutelou MG, Medrano R, Verani MS. Prognostic value of exercise thallium-201 tomography in patients treated with thrombolytic therapy during acute myocardial infarction. Circulation 1996;94:2735-42.
55. Travin MI, Dessouki A, Cameron T, Heller GV. Use of exercise technetium-99m sestamibi SPECT imaging to detect residual ischemia and for risk stratification after acute myocardial infarction. Am J Cardiol 1995;75:665-9.
56. Burns RJ, Gibbons RJ, Yi Q, Robets RS, Miller TD, Schaer GL, et al. The relationship of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis. J Am Coll Cardiol 2002;39:30-6.
57. Candell Riera J, Rius Daví A, Castell Conesa J, Aguadé Bruix S, Olona Cabases M, Permanyer Miralda G, et al. Valor pronóstico postinfarto de la función sistólica ventricular derecha. Rev Esp Cardiol 1995;48:115-21.
58. Zornoff LAM, Skali H, Pfeffer MA, Sutton MSJ, Rouleau JL, Lamas GA, et al. Right ventricular dysfunction and risk of heart failure and mortality after myocardial infarction. J Am Coll Cardiol 2002;39:1450-5.
59. Bailey JJ, Berson AS, Handelsman H, Hodges M. Utility of current risk stratification tests for predicting major arrhythmic events after myocardial infarction. J Am Coll Cardiol 2001; 38:1902-11.
60. Paganelli F, Barnay P, Imbert-Joscht I, Gelisse R, Saadjian A, Mundler O, et al. Influence of residual myocardial ischemia on induced ventricular arrhythmias following a first acute myocardial infarction. Eur Heart J 2001;22:1931-7.
61. Jaarsma W, Visser CA, Kupper AJF, Res JCJ, Van Eenige MJV, Roos JP. Usefulness of two-dimensional exercise echocardiography shortly after myocardial infarction. Am J Cardiol 1986;57:86-90.
62. Applegate RJ, Dell'Italia LJ, Crawford MH. Usefulness of two-dimensional echocardiography during low-level exercise testing early after uncomplicated acute myocardial infarction. Am J Cardiol 1987;60:10-4.
63. Quintana M, Lindvall K, Ryden L, Brolund F. Prognostic value of predischarge exercise stress echocardiography after acute myocardial infarction. Am J Cardiol 1995;76:1115-21.
64. González-Alujas T, Armada E, Alijarde M, Evangelista A, García-del-Castillo H, Soler-Soler J. Valor pronóstico de la ecocardiografía de esfuerzo postinfarto agudo de miocardio antes del alta hospitalaria. Rev Esp Cardiol 1998;51:21-6.
65. DePuey G, Nichols K, Dobrinsky C. Left ventricular ejection fraction assessed from gated technetium-99m-sestamibi SPECT. J Nucl Med 1993;34:1871-6.
66. Chua T, Kiat H, Germano G, Maurer G, Van Train K, Friedman J, et al. Gated technetium-99m sestamibi for simultaneous assessment of stress myocardial perfusion, postexercise regional ventricular function and myocardial viability. J Am Coll Cardiol 1994;23:1107-14.
67. Palmas W, Friedman JD, Diamond GA, Silber H, Kiat H, Berman DS. Incremental value of simultaneous assessment of myocardial function and perfusion with technetium-99m sestamibi for prediction of extent of coronary artery disease. J Am Coll Cardiol 1995;25:1024-31.
68. Smanio PE, Watson DD, Segalla DL, Vinson EL, Smith WH, Beller GA. Value of gating of technetium-99m sestamibi single-photon emission computed tomographic imaging. J Am Coll Cardiol 1997;30:1687-92.
69. Germano G, Erel J, Lewin H, Kavanagh PV, Berman DS. Automatic quantitation of regional myocardial wall motion and thickening from gated technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol 1997;30:1360-7.
70. Maunoury C, Chen CC, Chua KB, Thompson CJ. Quatification of left ventricular function with thallium-201 and technetium-99m-sestamibi myocardial gated -SPECT. J Nucl Med 1997;38:958-61.
71. Brown KA. Do stress echocardiography and myocardial perfusion imaging have the same ability to identify the low-risk patient with known or suspected coronary artery disease? Am J Cardiol 1998;81:1050-3.
72. Poldermans D, Fioretti PM, Boersma E, Cornel JH, Borst F, Vermeulen EGJ, et al. Dobutamine-atropine stress echocardiography and clinical data for predicting late cardiac events with suspected coronary artery disease. Am J Med 1994;97:119-25.
73. Sicari R, Picano E, Landi P, Pingitore A, Bigi R, Coletta C, et al. Prognostic value of dobutamine-atropine stress echocardiography early after acute myocardial infarction. J Am Coll Cardiol 1997;29:254-60.
74. Khattar RS, Basu SK, Raval U, Senior R, Lahiri A. Prognostic value of predischarge exercise testing, ejection fraction, and ventricular ectopic activity in acute myocardial infarction treated with streptokinase. Am J Cardiol 1996;78:136-41.
75. Pozzoli MMA, Fioretti PM, Salustri A, Reijs AEM, Roelandt JRTC. Exercise echocardiography and technetium-99m MIBI single-photon emission computed tomography in the detection of coronary artery disease. Am J Cardiol 1991;67:350-5.
76. O'Keefe JH, Barnhart CS, Bateman TM. Comparison of stress echocardiography and stress myocardial perfusion scintigraphy for diagnosing coronary artery disease and assessing its severity. Am J Cardiol 1995;75:25D-34D.
77. Quinones MA, Verani MS, Haichin RM, Mahmarian JJ, Suarez J, Zoghbi WA. Exercise echocardiography versus thallium-201 single-photon emission computed tomography in evaluation of coronary artery disease: analysis of 292 patients. Circulation 1992;95:1026-31.
78. Forster T, McNeill AJ, Salustri A, Reijs AEM, El-Said EM, Roelandt JRTC, et al. Simultaneous dobutamine stress echocardiography and technetium-99m isonitrile single-photon emission computed tomography in patients with suspected coronary artery disease. J Am Coll Cardiol 1993;21:1591-6.
79. Simeck CL, Watson DD, Smith WH, Vinson E, Kaul S. Dipyridamole thallium-201 imaging versus dobutamine echocardiography for the evaluation of coronary artery disease in patients unable to exercise. Am J Cardiol 1993;72:1257-62.
80. Amanullah AM, Chaudhry FA, Heo J, Galatro K, Dourdoufis P, Brozena S, et al. Comparison of dobutamine echocardiography, dobutamine sestamibi, and rest-redistribution thallium-201 single-photon emission computed tomography for determining contractile reserve and myocardial ischemia in ischemic cardiomyopathy. Am J Cardiol 1999;84:739-41.
81. Bonow RO. Diagnosis and risk stratification in coronary artery disease: nuclear cardiology versus stress echocardiography. J Nucl Cardiol 1997;4:S172-8.
82. Marwick TH, Nemee JJ, Pashkow FJ, Stewart WJ, Salcedo EE. Accuracy and limitations of exercise echocardiography in a routine clinical practice. J Am Coll Cardiol 1992;19:74-81.
83. Panza JA, Laurienzo JM, Quyymi AA, Cannon RO. Transesophageal dobutamine stress echocardiography for evaluation of patients with coronary artery disease. J Am Coll Cardiol 1994; 24: 1260-7.
84. Tauke JT, Wiet SP, Shelton-Zoiopoulos LY, Greenfieldet S, Tommaso CL, Bonow RO, et al. Simultaneous transthoracic and transesophageal dobutamine stress echocardiography [abstract]. J Am Coll Cardiol 1994;23:360A.
85. Hoffman R, Lethen H, Marwick T, Arnese M, Fioretti P, Pingitore A, et al. Analysis of interinstitutional observer agreement in interpretation of dobutamine stress echocardiograms. J Am Coll Cardiol 1996;27:330-6.
86. Alderman EL, Fisher LD, Litwin P, Kaiser GC, Myers WO, Maynard C, et al. Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation 1983; 68:785-95.
87. Bounous EP, Mark DB, Pollock BG, Hlatky MA, Harrel FE Jr, Lee KL, et al. Surgical survival benefits for coronary disease patients with left ventricular dysfunction. Circulation 1988;78:1151-7.
88. Baker DW, Jones R, Hodges J, Massie BM, Konstam MA, Rose EA. Management of heart failure. III. The role of revascularization in the treatment of patients with moderate or severe left ventricular systolic dysfunction. JAMA 1994;272:1528-34.
89. Freeman AP, Walsh WF, Giles RW, Choy D, Newman DC, Horton DA, et al. Early and long term results of coronary artery bypass grafting with severely depressed left ventricular performance. Am J Cardiol 1984;54:749-54.
90. Bax JJ, Poldermans D, Elhendy A, Cornel JH, Boersma E, Rambaldi R, et al. Improvement of left ventricular ejection fraction. J Am Coll Cardiol 1999;34:163-9.
91. Afridi I, Kleiman NS, Raizner AE, Zoghbi WA. Dobutamine echocardiography in myocardial hibernation. Optimal dose and accuracy in predicting recovery of ventricular function after myocardial coronary angioplasty. Circulation 1995;91: 663-70.
92. Smart SC, Knickelbine T, Stoiber TR, Carlos M, Wynsen JC, Sagar KB. Safety and accuracy of dobutamine-atropine stress echocardiography for the detection of residual stenosis of the infarcted related artery and multivessel disease during the first week after acute myocardial infarction. Circulation 1997;95: 1394-401.
93. De la Torre MM, San Román JA, Bermejo J, Garcimartín I, Paniagua J, Sanz O, et al. Valor pronóstico de la ecocardiografía con dobutamina después de un infarto agudo de miocardio. Rev Esp Cardiol 1999;52:237-44.
94. Peral V, Vilacosta I, Fernández C, Hernández M, San Román JA, Batlle E, et al. Comparación entre la eco-dobutamina y talio-201 SPECT reposo-redistribución en la valoración de la viabilidad miocárdica considerando el PET como patrón oro. Rev Esp Cardiol 2001;54:1394-405.
95. Piérard LA, De Landsheere CM, Berthe C, Rigo P, Kulbertus HE. Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: comparison with positron emission tomography. J Am Coll Cardiol 1990;15:1021-31.
96. Bax JJ, Wijns W, Cornel JH, Visser FC, Boersma E, Fioretti PM. Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled date. J Am Coll Cardiol 1997;30:1451-60.
97. Poldermans D, Sozzi FB, Bax JJ, Boersma E, Duncker DJ, Vourvouri E, et al. Influence of continuation of beta blockers during dobutamine stress echocardiography for the assessment of myocardial viability in patients with severe ischemic left ventricular dysfunction. Am J Cardiol 2001;88:68-70.
98. Dilsizian V, Rocco TP, Freedman NMT, Leon MB, Bonow RO. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med 1990;323:141-6.
99. 99mTc-sestamibi with thallium-201 reinjection and (18F)fluorodeoxyglucose. Circulation 1994;89:578-87.
100. Flotats A, Carrió I, Estorch M, Bernà L, Catafau AM, Marí C, et al. Nitrate administration to enhance the detection of myocardial viability by technetium-99m tetrofosmin single-photon emission tomography. Eur J Nucl Med 1997;24:767-73.
101. 99m-Tc-MIBI en la predicción de la recuperabilidad de la función contráctil posrevascularización. Resultados del protocolo multicéntrico español. Rev Esp Cardiol 2000;53:903-10.
102. Bonow RO, Dilsizian V, Cuocolo A, Bacharach SL. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of Thallium scintigraphy with reinjection and PET imaging with 18F-Fluorodeoxyglucose. Circulation 1991;83:26-37.
103. Castell J, Candell-Riera J, Roselló-Urgell J, Fraile López-Amor M, Hornero-Sos F, Aguadé-Bruix S, et al. Valoración de la viabilidad miocirádica mediante tecnecio-99m isonitrilo y talio-201. Resultados del protocolo multicéntrico español. Rev Esp Cardiol 1997;50:320-30.
104. Sibelink HJ, Blanksma PK, Crijns HJGM, Bax JJ, Van Boven AJ, Kingma T, et al. No difference in cardiac event-free survival between positron emission tomography-guided and single-photon emission computed tomography-guided management. A prospective, randomized comparison in patients with suspicion of jeopardized myocardium. J Am Coll Cardiol 2001;37: 81-8.
105. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, et al. The use of contrast enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343:1445-53.
106. Di Carli MF. Assessment of myocardial viability after myocardial infarction. J Nucl Cardiol 2002;9:229-35.
107. Eitzman D, Al-Aouar Z, Kanter HL, Vom Dahl J, Kirsh M, Deeb GM, et al. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol 1992;20:559-65.
108. Di Carli MF, Davidson M, Little R, Khanna S, Mody FV, Brunken RC, et al. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 1994;73:527-33.
109. Lee KS, Marwick TH, Cook SA, Go RT, Fix JS, James KB, et al. Prognosis of patients with left ventricular function, with and without viable myocardium after myocardial infarction. Relative efficacy of medical therapy and revascularization. Circulation 1994;90:2687-94.
110. Vom Dahl J, Altehoefer C, Sheehan FH, Buechin P, Schulz G, Schwarz ER, et al. Effect of myocardial viability assessed by technetium-99m-sestamibi SPECT and fluorine-18-FDG PET on clinical outcome in coronary artery disease. J Nucl Med 1997;38:742-8.
111. Afridi I, Grayburn PA, Panza JA, Oh JK, Zoghbi WA, Marwick TH. Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction. J Am Coll Cardiol 1998;32:921-6.
112. Cuocolo A, Petretta M, Nicolai E, Pace L, Bonaduce D, Salvatore M, et al. Successful coronary revascularization improves prognosis in patients with previous myocardial infarction and evidence of viable myocardium at thallium-201 imaging. Eur J Nucl Med 1998;25:60-8.
113. Pasquet A, Robert A, D'Hondt AM, Dion R, Melin JA, Vanoverschelde JL. Prognostic value of myocardial ischemia and viability in patients with chronic left ventricular ischemic dysfunction. Circulation 1999;100:141-8.
114. Chaudhry FA, Tauke JT, Alessandrini RS, Vardi G, Parker MA, Bonow RO. Prognostic implications of myocardial contractile reserve in patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol 1999;34:730-8.
115. Rohatgi R, Epstein S, Henriquez J, Ababneh AA, Hickey KT, Pinsky D, et al. Utility of positron emission tomography in predicting cardiac events and survival in patients with coronary artery disease and severe left ventricular dysfunction. Am J Cardiol 2001;87:1096-9.
116. Yamaguchi A, Ino T, Adachi H, Murata S, Kamio H, Okada M, et al. Left ventricular volume predicts postoperative course in patients with ischemic cardiomyopathy. Ann Thorac Surg 1998; 65:434-8.
117. Santana CA, Soler-Peter M, DiCarli MF, Krawczynska EG, Faber TL, Folks RD, et al. Prognostic value of left ventricular function determined by ECG-gated FDG PET. J Nucl Cardiol 2002;9:S4.
118. Yoshida K, Gould KL. Quantitative relation of myocardial infarct size and myocardial viability by positron emission tomography to left ventricular ejection fraction and 3-year mortality with and without revascularization. J Am Coll Cardiol 1993;22:984-97.
119. Paolini G, Lucignani G, Zuccari M, Landoni C, Vanoli G, Di Credico G, et al. Identification and revascularization of hibernating myocardium in angina free patients with left ventricular dysfunction. Eur J Cardiothorac Surg 1994;8:139-44.
120. Epstein SE, Palmeri ST, Patterson RE. Evaluation of patients after myocardial infarction. Indications for cardiac revascularization and surgical intervention. N Engl J Med 1982;307:1487-92.
121. Cohn PF. The role of noninvasive cardiac testing after an uncomplicated myocardial infarction. N Engl J Med 1983;308:90-3.
122. Crawford MH, O'Rourke RA. The role of cardiac catheterization in patients after myocardial inarction. Cardiology Clinics 1984;2:105-11.
123. Nienaber CA, Bleifeld W. Personal view: In-hospital patient management strategies after acute myocardial infarction. Eur Heart J 1985:6:640-6.
124. Iskandrian AS, Hakki A, Kotler MN, Segal BL, Herling I. Evaluation of patients with acute myocardial infarction: Which test, for whom and why? Am Heart J 1985;109:391-4.
125. Handler CE. Investigation of symptom free patients after myocardial infarction. Br Heart J 1986;55:531-4.
126. DeBusk RF, Blomqvist CG, Kouchoukos NT, Luepker RV, Miller HS, Moss AJ, et al. Identification and treatment of low-risk patients after acute myocardial infarction and coronary-artery bypass graft surgery. N Engl J Med 1986;314:161-6.
127. Gillespie JA, Moss AJ. Postinfarction risk profiling: Past, present and future considerations. J Am Coll Cardiol 1986;8:50-1.
128. Beller GA, Gibson RS. Risk stratification after myocardial in farction. Mod Concepts Cardiovasc Dis 1986;55:5-9.
129. O'Rourke RA. Clinical decisions for postmyocardial infarction patients. Mod Concepts Cardiovasc Dis 1986;55:55-9.
130. Moss AJ, Bigger JT, Odoroff CL. Postinfarct risk stratification. Progr Cardiovasc Dis 1987;29:389-412.
131. Cobb FR, Chu A. Myocardial infarction and risk region relationships: Evaluation by direct and non invasive methods. Progr Cardiovasc Dis 1988;30:323-48.
132. Ross J Jr, Gilpin EA, Madsen EB, Henning H, Nicod P, Dittrich H, et al. A decision scheme for coronary angiography after acute myocardial infarction. Circulation 1989;79:292-303.
133. DeBusk RF. Specialized testing after recent acute myocardial infarction. Ann Intern Med 1989;110:470-81.
134. American College of Physicians. Evaluation of patients after recent acute myocardial infarction. Ann Intern Med 1989;110:485-8.